Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
This open, prospective study systematically examined the clinical efficacy of itraconazole and initial flucytosine in AIDS-associated cryptococcal meningitis. Clinical as well as mycological responses were evaluated in 10 patients. Satisfactory outcome was achieved in 8 patients (cure in 4 and improvement in 4). In all, 5 patients died, three as a result of cryptococcal meningitis. The remaining 5 patients have been followed for 5-12 months. The treatment proved to be well-tolerated and safe.